Vendor, Claremont, CA
Synedgen, Inc.
UEI HX79BD6YQ521, CAGE 5JGC8
2 awards and $21,126,078 obligated between September 19, 2024 and September 26, 2025, 50% under full and open competition, against 1.0 offers on average where reported. 8 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $18,828,663 |
| Defense Health Agency | $2,297,415 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $21,126,078 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00047Definitive Contract, September 26, 2024, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance the Development of Paag17g (Drug Product: Miist305), a Once Daily, Orally Administered, Gut-Restricted Drug, to Reduce Mortality andNAICS 541715, PSC AN13 | $18,828,663 |
| HT942524C0049Definitive Contract, September 19, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | Army Med Res Acq ActivityDefense Health Agency | SBIR Phase III Proposal No. JW230017 Titled, "optimized, Field-Stable Glycopolymer-Mimicking Polysaccharide to Prevent Morbidity and MortaliNAICS 541715, PSC AN12 | $2,297,415 |
- Places of performance
- California
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental DevelopmentAN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 7 across 2 awards